Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gayla B. Herschler"'
Autor:
Charles Fewlass, Dianne Harvey, Nadine Zimmerman, Gayla B. Herschler, W. Paul Glezen, Manjusha Gaglani, Claudia A. Kozinetz, Pedro A. Piedra
Publikováno v:
Pediatrics. 120:e553-e564
OBJECTIVE. Live attenuated influenza vaccine may protect against wild-type influenza illness shortly after vaccine administration by innate immunity. The 2003–2004 influenza A (H3N2) outbreak arrived early, and the circulating strain was antigenica
Autor:
Charles Fewlass, W. Paul Glezen, Manjusha Gaglani, Matt Watts, Gayla B. Herschler, Claudia A. Kozinetz, Colin Hessel, Pedro A. Piedra, Mark W. Riggs
Publikováno v:
Pediatrics. 116:e397-e407
Objective. Influenza-associated deaths in healthy children that were reported during the 2003–2004 influenza season heightened the public awareness of the seriousness of influenza in children. In 1996–1998, a pivotal phase III trial was conducted
Autor:
Matt Watts, Julie Cordova, W. Paul Glezen, Manjusha Gaglani, Pedro A. Piedra, Mark W. Riggs, Claudia A. Kozinetz, Charles Fewlass, Melissa Griffith, Colin Hessel, Gayla B. Herschler
Publikováno v:
Vaccine. 23:1540-1548
Highest attack rates for influenza occur in children. Immunization of schoolchildren with inactivated influenza vaccine in Michigan and Japan was associated with decreased morbidity and mortality, respectively, in older community contacts. An open-la
Autor:
M. Elizabeth Halloran, W. Paul Glezen, Manjusha Gaglani, Pedro A. Piedra, Gayla B. Herschler, Haitao Chu, Ira M. Longini
Publikováno v:
American Journal of Epidemiology. 158:305-311
The authors report on a community-based, nonrandomized, open-label study, conducted during the 2000-2001 influenza season in Temple-Belton, Texas, of the protective effectiveness of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) in childre
Autor:
Claudia A. Kozinetz, Melissa Griffith, W. Paul Glezen, Manjusha Gaglani, Gayla B. Herschler, Pedro A. Piedra, Mark W. Riggs
Publikováno v:
International Congress Series. 1219:939-943
Background : We report on the safety and effectiveness of trivalent, cold-adapted influenza vaccine (CAIV-T) in children in the largest community trial to date. Methods : Enrolled children 18 months through 18 years of age received CAIV-T in years 1
Autor:
Charles Fewlass, W. Paul Glezen, Gayla B. Herschler, Manjusha Gaglani, Pedro A. Piedra, Mark W. Riggs
Publikováno v:
The Pediatric infectious disease journal. 27(5)
Background Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with asthma is unknown. A previous report showed an "asthma signal" in children aged 18-35 months. Methods Healthy children aged 1.5-18 years with hi
Autor:
M. Elizabeth Halloran, Gayla B. Herschler, Ira M. Longini, W. Paul Glezen, Manjusha Gaglani, Brian Schmotzer, Pedro A. Piedra, Charles Fewlass
In the 2003–2004 influenza season, the predominant circulating influenza A (H3N2) virus in the United States was similar antigenically to A/Fujian/411/2002 (H3N2), a drift variant of A/Panama/2007/99 (H3N2), the vaccine strain. That year, a field s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a463f43e3f6d8709af5582130ad6beb9
https://europepmc.org/articles/PMC2883284/
https://europepmc.org/articles/PMC2883284/
Autor:
Manjusha Gaglani, Gayla B. Herschler
Publikováno v:
Clinical pediatrics. 43(1)
Influenza is a vaccine-preventable disease. However, influenza virus spreads among children in schools and daycare centers, then to families and communities, causing uncontrolled epidemics every winter. The United States Food and Drug Administration
Autor:
Gayla B. Herschler, Ira M. Longini, Pedro A. Piedra, Mark W. Riggs, Charles Fewlass, M. Elizabeth Halloran, Claudia A. Kozinetz, Melissa Griffith, W. Paul Glezen, Manjusha Gaglani
Publikováno v:
Archives of Pediatrics & Adolescent Medicine. 158:65
Background The efficacy of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine (CAIV-T) against influenza A(H3N2) and B infections in healthy persons is established, but its effectiveness against natural influenza A(H1N1)
Autor:
Chu, Haitao, Halloran, M. Elizabeth
Publikováno v:
Statistics in Medicine; Sep2004, Vol. 23 Issue 17, p2697-2711, 15p